Atlanta, Georgia, United StatesFounded 201630+ employeesPrivate
$27.9M raisedSeries A· last: series b (Oct 2024)· 6 rounds
Backed by(6 investors)
OncoLens is an oncology-focused digital health platform that enhances cancer care through AI-driven analytics and multidisciplinary collaboration tools. By leveraging structured and unstructured data, OncoLens improves patient outcomes and revenue opportunities by preventing patient leakage and proactively identifying patients for clinical trials, biomarker testing or other key services. The platform’s analytics tools enable both centers and industry to derive insights into patient cohorts, identify new opportunities and improve quality. The OncoLens Research Network collaborates with industry partners to bring curated research and real world evidence initiatives to cancer centers. Contact us at [email protected] for a demo.
